Diagnostics Solutions Strategic Priorities
Supporting patient journeys with our oncology pipeline
Pharma partner of choice, driving personalised healthcare
Roche
+2
Screening
Diagnosis & Classification
Prognosis¹
Therapy selection2
+3
+21
250+
+5
+27
+4
380
Monitoring/Surveillance
+5
+10
+7
13
LUJUL
3
+2
+1
1
1
+4
8
5
+1
2
+2
1
1
+1
+1
10
7
5
3
1
+1
+1
wwww
H
IA
IHC
PCR
Algorithms
IA
IHC
PCR
Algorithms
IA
IHC
NGS
Algorithms
IA
(CA 19-9)
(Ki67)
(EGFR)
(CA 19-9)
(Ki67)
(EGFR)
(CA 19-9)
(Ki67)
(CA 19-9)
IHC
(Ki67)
PCR
(EGFR)
NGS
Algorithms
IA
(CA 19-9)
PCR
(EGFR)
NGS
Algorithms
Immunoassay (IA)
1 Predicting the likely or expected development of a disease
2 On-label CDx indications
Decision support: NAVIFY Mutation Profiler, NAVIFY Tumor Board, NAVIFY guidelines
+ Patient Journey, Guidelines adherence tracking, quality reporting, therapy matching
Immunohistochemistry (IHC)
H Next Gen Sequencing (NGS)
MIX
65
Polymerase Chain Reaction (PCR)
AlgorithmsView entire presentation